TCI Wealth Advisors, Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,0000.0%3000.0%0.00%
Q2 2021$1,0000.0%3000.0%0.00%
Q1 2021$1,0000.0%3000.0%0.00%
Q4 2020$1,0000.0%3000.0%0.00%
Q3 2020$1,0000.0%3000.0%0.00%
Q2 2020$1,0000.0%3000.0%0.00%
Q1 2020$1,0000.0%3000.0%0.00%
Q4 2019$1,0000.0%3000.0%0.00%
Q3 2019$1,0000.0%3000.0%0.00%
Q2 2019$1,000
-50.0%
3000.0%0.00%
-100.0%
Q1 2019$2,000
+100.0%
3000.0%0.00%
Q4 2018$1,000
-50.0%
3000.0%0.00%
-100.0%
Q3 2018$2,0000.0%3000.0%0.00%0.0%
Q2 2018$2,000
+100.0%
3000.0%0.00%
Q1 2018$1,0000.0%3000.0%0.00%
Q4 2017$1,0000.0%3000.0%0.00%
Q3 2017$1,0000.0%3000.0%0.00%
-100.0%
Q2 2017$1,0000.0%3000.0%0.00%0.0%
Q1 2017$1,0003000.0%0.00%
Q4 2016$03000.0%0.00%
Q3 2016$03000.0%0.00%
Q2 2016$03000.0%0.00%
Q1 2016$03000.0%0.00%
Q4 2015$0
-100.0%
3000.0%0.00%
-100.0%
Q3 2015$1,0000.0%3000.0%0.00%0.0%
Q2 2015$1,0000.0%3000.0%0.00%0.0%
Q1 2015$1,0000.0%3000.0%0.00%0.0%
Q4 2014$1,000
-50.0%
3000.0%0.00%0.0%
Q3 2014$2,000
-50.0%
3000.0%0.00%
-50.0%
Q2 2014$4,000
-20.0%
3000.0%0.00%
-33.3%
Q1 2014$5,0003000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders